PTCase ReportFrontiers in rehabilitation sciences2023

Therapeutic hypothermia as a neuroprotective strategy in newborns with perinatal asphyxia-case report.

Nayara Rodrigues Gomes de Oliveira, Gustavo Gonçalves Teixeira, Kathlen Terezinha Montes Soares Fernandes and 3 others

PMID 37152243

WHAT IT FOUND

Two newborns with birth asphyxia who received cooling therapy showed typical motor development and no neurological sequelae at follow-up.

Because this is only two cases, it does not prove cooling works, but it illustrates how to monitor high-risk infants for early motor delays.

Key findings

01Both newborns were treated with therapeutic hypothermia for 72 hours following perinatal asphyxia and hypoxic-ischemic encephalopathy.

02At follow-up, the child from case 1 showed typical development but risk of language delay, while the child from case 2 improved from motor delay to typical development across assessments.

03The authors concluded that the results suggest therapeutic hypothermia can serve as a neuroprotective strategy to minimize neurological sequelae.

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Only two cases, so results cannot be generalized to all infants with perinatal asphyxia. No control group, so it is impossible to separate the effect of cooling from natural recovery or other treatments. Instruments were not applied in a standardized way for both cases. Follow-up started late for both children (18 months for Case 1, 6 months for Case 2), missing early developmental windows. MRI was only performed during the NICU stay, not during follow-up.

The easy way to misread this

Do not interpret the positive outcomes in these two cases as proof that therapeutic hypothermia prevents cerebral palsy or neurological sequelae. This is a case report without a control group, so it cannot demonstrate efficacy.

Read it on PubMed →